Wingspire Capital provided a $45 million revolving credit facility to a global medical device maker that develops, manufactures and markets a portfolio of spinal surgery products. Proceeds are being used to refinance the previous capital structure. Wingspire Capital provided a more flexible credit facility with greater liquidity to support the company’s continued growth.
“We enjoyed working closely with the borrower and sponsor on a creative and nimble solution, allowing the borrower to focus on growing its business,” Katie Thornett, managing director at Wingspire Capital, said.
